# Generated benchmark review

Seed: `20261014`  
Generator: `gemini-3.5-flash-lite`

## real-0006 (dev)

**Question:** How do traditional statistical methods for handling multi-scale data assume underlying data distributions, and why does this motivate min-max normalization?

**Answerable:** True  
**Type:** comparison  
**Verified by:** auto  
**Reference:** Traditional methods assume data are approximately normally distributed, but bias metrics exhibit highly skewed distributions, prompting a scale-invariant min-max normalization approach.

**Evidence:** Ayush & Aman - BIAS IEEE PAPER.pdf · page 3

> Traditional statistical methods for handling multi- scale data-such as z-score normalization or robust standardization-assume that underlying data are approx- imately normally distributed. However, bias metrics typi- cally exhibit highly skewed distributions, particularly tox- icity scores (often clustered near zero) and representation ratios (often bimodal). This motivated development of a scale-invariant normalization approach: min-max normal- ization.

---
## real-0020 (dev)

**Question:** How do the findings regarding the efficacy and evaluation of agents without documented single-agent activity in cancer combination trials relate to the obstacles and prevalence of traditional healing practices for treating jaundice?

**Answerable:** True  
**Type:** comparison  
**Verified by:** auto  
**Reference:** Both documents examine evaluation paradigms and challenges within medical or therapeutic contexts, where esmoopen-2020-000871.pdf discusses the low yield and lack of clinical activity when incorporating agents without single-agent activity into cancer treatment regimens, while pone.0312962.pdf explores obstacles such as legality issues, availability constraints, and lack of scientific evidence facing traditional healing practices for jaundice.

**Evidence:** esmoopen-2020-000871.pdf · page 6

> Our key finding is that incorporating agents without documented single-­agent activity into treatment regi- mens is unlikely to produce meaningful improvements in clinical activity.

**Evidence:** pone.0312962.pdf · page 10

> Obstacles for traditional healing practices: Healers perspective Legality issues. The legal recognition of traditional healing practices is a significant bar- rier for the healers.

---
## real-0030 (dev)

**Question:** How do the research priorities discussed in the Molecular & Cellular Proteomics journal relate to the health conditions investigated in jaundiced patients in Bangladesh?

**Answerable:** True  
**Type:** comparison  
**Verified by:** auto  
**Reference:** While the Molecular & Cellular Proteomics journal focuses on proteomics, protein biology, and biomarker discovery for major diseases including cardiovascular and infectious diseases, the study in Bangladesh investigates push and pull factors influencing jaundiced patients to choose traditional medicine over conventional medicine.

**Evidence:** pone.0312962.pdf · page 2

> The study reveals that both push and pull factors influence jaundiced patients in Bangladesh to choose TM over CM, with decisions shaped by personal, socioeconomic, and geographi- cal factors.

**Evidence:** zjw2214.pdf · page 1

> MCP will continue to serve the proteomics community with original contributions that enhance our knowledge in the general areas of protein biology of living systems and the biomedical sciences.

---
## real-0040 (dev)

**Question:** In what ways do the new research interests and technical methodologies described for editorial leaders like Steven A. Carr in molecular proteomics contrast with the multi-stage mitigation strategies used for generative AI bias?

**Answerable:** True  
**Type:** comparison  
**Verified by:** auto  
**Reference:** Editorial leaders like Steven A. Carr focus on developing proteomics technologies to quantify proteins, modifications, and biomarkers in health and disease, whereas AI bias mitigation strategies involve dataset curation, debiased word embeddings, instruction tuning, and conditional generation with fairness constraints.

**Evidence:** zjw2214.pdf · page 1

> His laboratory fo- cuses on the development and application of new tech- nologies to quantify proteins, their modifications and in- teraction partners in health and disease, in order to understand the function of proteins and especially their response and resistance to drugs.

**Evidence:** Ayush & Aman - BIAS IEEE PAPER.pdf · page 8

> 9.1. Overview of Multi-Stage Mitigation Ap- proaches Addressing bias in generative AI systems requires com- prehensive, multi-layered mitigation strategies operating at different model development and deployment stages.

---
## real-0009 (heldout)

**Question:** What connection is made between regulatory compliance requirements in AI and clinical trial classifications?

**Answerable:** True  
**Type:** comparison  
**Verified by:** auto  
**Reference:** The AI paper mentions that regulations like the EU AI Act require bias documentation without standardized metrics, whereas the clinical paper uses defined criteria such as 'positive', 'negative', or 'unknown' based on target accrual and published primary analyses to classify trial results.

**Evidence:** Ayush & Aman - BIAS IEEE PAPER.pdf · page 3

> 4. Regulatory Compliance: The EU AI Act [35] and other regulations require bias documentation, but without standardized metrics, compliance documentation is am- biguous.

**Evidence:** esmoopen-2020-000871.pdf · page 3

> Once single-­agent activity was assessed for the exper- imental agent in each trial, the trial publications were reviewed, and results were classified as ‘positive’, ‘negative’ or ‘unknown’ based on the following criteria.

---
## real-0031 (heldout)

**Question:** In what ways do the editorial leadership changes described for Molecular & Cellular Proteomics contrast with the patient perspectives on healthcare choices for jaundice described in Bangladesh?

**Answerable:** True  
**Type:** comparison  
**Verified by:** auto  
**Reference:** Molecular & Cellular Proteomics announces structural and editorial additions such as Deputy and Associate Editors to improve manuscript review efficiency, whereas the Bangladesh study details qualitative perspectives of patients deciding between traditional healers and hospitals for conditions like jaundice.

**Evidence:** pone.0312962.pdf · page 8

> The thematic analysis of the FGD and interviews uncovered several recurring themes illumi- nating the complex dynamics surrounding traditional healing practices and the factors influ- encing decision-making when choosing treatment.

**Evidence:** zjw2214.pdf · page 1

> With this issue, a long-standing member of our Editorial Board, Natalie Ahn, becomes President of our Society. Also with this issue, I am delighted to announce a number of editorial changes designed to expand and broaden our sci- entific leadership.

---
## real-0039 (heldout)

**Question:** How does the editorial focus on quantitative proteomics described by Alma L. Burlingame in MCP compare to the mitigation of algorithmic and NBRS bias metrics across generative models discussed in the IEEE paper?

**Answerable:** True  
**Type:** comparison  
**Verified by:** auto  
**Reference:** Alma L. Burlingame's editorial discusses shifting towards reproducible protein quantification in proteomics and systems biology to understand biological phenotypes, whereas the IEEE paper compares models using NBRS bias scores across modalities like text, image, and video to evaluate and mitigate demographic representation biases.

**Evidence:** zjw2214.pdf · page 2

> A major focus of proteomics, and therefore of MCP, has shifted toward reproducible quantifica- tion—rather than simple enumeration—of proteins and their modifications across biological samples in a range of states.

**Evidence:** Ayush & Aman - BIAS IEEE PAPER.pdf · page 6

> TABLE 1. COMPARATIVE BIAS SCORES: EXISTED METHODS VS. NBRS UNIFIED APPROACH Model WEAT Sentiment Toxicity Avg (Direct) NBRS Comparison Claude-2 0.32 0.15 0.08 0.183* 0.30

---
## real-0004 (dev)

**Question:** What is the definition of temporal sentiment consistency as mentioned in the evaluation metrics?

**Answerable:** True  
**Type:** definition  
**Verified by:** auto  
**Reference:** It analyzes whether emotional framing remains consistent for demographic groups.

**Evidence:** Ayush & Aman - BIAS IEEE PAPER.pdf · page 3

> 3. Temporal Sentiment Consistency: Analyzes whether emotional framing remains consistent for demographic groups [47]. Range: −1 to +1.

---
## real-0023 (dev)

**Question:** How is jaundice medically defined in terms of serum bilirubin levels?

**Answerable:** True  
**Type:** definition  
**Verified by:** auto  
**Reference:** It is a medical condition characterized by yellowing of the skin and sclera due to elevated bilirubin levels in the blood, typically becoming noticeable when serum bilirubin exceeds 3 mg/dl.

**Evidence:** pone.0312962.pdf · page 2

> Jaundice is a medical condition characterized by yellowing of the skin and sclera (white por- tion of the eyes) due to elevated bilirubin levels in the blood, typically becoming noticeable when serum bilirubin exceeds 3 mg/dl [1].

---
## real-0036 (heldout)

**Question:** What field is focused on the analysis of small molecules in living systems and shares common analysis platforms with proteomics?

**Answerable:** True  
**Type:** definition  
**Verified by:** auto  
**Reference:** Metabolomics

**Evidence:** zjw2214.pdf · page 3

> Metabolomics is focused on the analysis of small molecules in living systems and shares common analysis platforms with proteomics.

---
## real-0018 (dev)

**Question:** What was the exact financial grant amount provided by the National Institutes of Health to fund the ESMO Open review by Foster et al.?

**Answerable:** False  
**Type:** factual  
**Verified by:** auto  
**Reference:** (none)

**Evidence:** none (generated as unanswerable)

---
## real-0035 (dev)

**Question:** What academic institution is associated with Thomas Neubert's position as Associate Professor of Pharmacology and Skirball Institute Program in Structural Biology?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** New York University School of Medicine

**Evidence:** zjw2214.pdf · page 1

> Thomas Neubert is Associate Professor of Pharmacology and Skirball Institute Program in Structural Biology, New York University School of Medicine (Fig. 4).

---
## real-0002 (dev)

**Question:** According to the modality-specific analysis by NBRS, which two models tied as the fairest models with an NBRS score of 0.30?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** DALL-E 3 and Claude-2

**Evidence:** Ayush & Aman - BIAS IEEE PAPER.pdf · page 9

> DALL-E 3 and Claude-2 (NBRS 0.30) tied as fairest models.

---
## real-0021 (dev)

**Question:** What are the common causes of acute jaundice in resource-limited countries like Bangladesh where fecal contamination of drinking water is prevalent?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** Hepatitis E (HEV), Hepatitis A (HAV), and acute Hepatitis B are the most common causes of acute jaundice in such settings.

**Evidence:** pone.0312962.pdf · page 2

> In resource-limited countries like Bangladesh, where fecal contamination of drinking water is common, Hepatitis E (HEV), Hepatitis A (HAV), and acute Hepatitis B are the most common causes of acute jaundice [2, 3].

---
## real-0038 (dev)

**Question:** What specific software package was used by Steven A. Carr's laboratory to process mass spectrometry data in 2015?

**Answerable:** False  
**Type:** factual  
**Verified by:** auto  
**Reference:** Proteome Discoverer

**Evidence:** none (generated as unanswerable)

---
## real-0007 (dev)

**Question:** What exact hardware architecture and GPU count were utilized to train the specific variant of CogVideoX analyzed in the NBRS benchmark?

**Answerable:** False  
**Type:** factual  
**Verified by:** auto  
**Reference:** The provided text does not mention the hardware architecture or GPU count used for training CogVideoX.

**Evidence:** none (generated as unanswerable)

---
## real-0011 (dev)

**Question:** According to the methods section, what starting date was used to search the CTEP trials database for randomised comparative phase II trials?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** 1 January 2008

**Evidence:** esmoopen-2020-000871.pdf · page 2

> The CTEP trials database was searched for randomised comparative phase II trials involving more than one agent (including radiation) that were activated on or after 1 January 2008 and were permanently closed to accrual by 31 December 2017.

---
## real-0032 (dev)

**Question:** Who is the author of the editorial on strengthening the MCP editorial leadership?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** Alma L. Burlingame

**Evidence:** zjw2214.pdf · page 1

> On Strengthening the MCP Editorial Leadership Alma L. Burlingame‡

---
## real-0001 (dev)

**Question:** What are the three principles that form the theoretical foundation of min-max normalization as described in the paper?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** Order Preservation, Boundary Correspondence, and Scale Invariance.

**Evidence:** Ayush & Aman - BIAS IEEE PAPER.pdf · page 3

> The theoretical foundation rests on three principles: Principle 1 - Order Preservation: If xi > xj in original scale, then norm(xi) > norm(xj) in normalized scale. This preserves the ranking of models-a fundamental requirement for any fair bias comparison. Principle 2 - Boundary Correspondence: The extreme values (minimum and maximum observed) map to 0 and 1, respectively, providing interpretable bounds [30]. Principle 3 - Scale Invariance: The transformation is independent of original scales-a WEAT score on scale [-1, +1] transforms identically to a Toxicity score on scale [0, 1], provided their positions within their respective ranges are identical.

---
## real-0008 (dev)

**Question:** What specific funding agency or institutional grant provided financial backing for the creation of the NBRS framework?

**Answerable:** False  
**Type:** factual  
**Verified by:** auto  
**Reference:** The text does not report any funding agency or institutional grant details for the NBRS framework.

**Evidence:** none (generated as unanswerable)

---
## real-0033 (dev)

**Question:** What new roles have Steven A. Carr and Anne-Claude Gingras agreed to assume?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** Deputy Editors

**Evidence:** zjw2214.pdf · page 1

> Steven A. Carr and Anne-Claude Gingras have agreed to assume new roles as Deputy Editors and will function with me as the new journal leadership and management team.

---
## real-0012 (dev)

**Question:** Based on Table 1 guidelines, what conclusion about single-agent activity is given when there are more than 20 evaluable patients and the observed response rate is less than 5%?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** Inactive

**Evidence:** esmoopen-2020-000871.pdf · page 2

> n>20 >5% <5% --

---
## real-0017 (heldout)

**Question:** Which specific clinical trial is highlighted as the most clear-cut example of a positive clinical trial for an agent without single-agent activity?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** S1406

**Evidence:** esmoopen-2020-000871.pdf · page 6

> As noted above, the most clear-­cut example of a positive clinical trial for an agent without single-­agent activity is S1406, which evaluated the addition of vemurafenib to irinotecan and cetuximab for BRAF-­mutant metastatic colorectal cancer.

---
## real-0037 (heldout)

**Question:** What was the exact date when the manuscript by Alma L. Burlingame was received by the journal?

**Answerable:** False  
**Type:** factual  
**Verified by:** auto  
**Reference:** June 8, 2016

**Evidence:** none (generated as unanswerable)

---
## real-0028 (heldout)

**Question:** What was the exact average age of participants seeking traditional healing in the urban cohort of the study?

**Answerable:** False  
**Type:** factual  
**Verified by:** auto  
**Reference:** The provided text does not contain the exact average age of participants in the urban cohort.

**Evidence:** none (generated as unanswerable)

---
## real-0029 (heldout)

**Question:** Which specific government grant number funded the clinical trial for evaluating jaundice herbal remedies in Dhaka?

**Answerable:** False  
**Type:** factual  
**Verified by:** auto  
**Reference:** The text does not mention any government grant number funding a clinical trial for evaluating jaundice herbal remedies in Dhaka.

**Evidence:** none (generated as unanswerable)

---
## real-0010 (heldout)

**Question:** What is the specific doi assigned to the ESMO Open 2020 article by Foster et al.?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** 10.1136/esmoopen-2020-000871

**Evidence:** esmoopen-2020-000871.pdf · page 2

> Foster J, et al. ESMO Open 2020;5:e000871. doi:10.1136/esmoopen-2020-000871

---
## real-0027 (heldout)

**Question:** What potential adverse effects on the liver have contemporary evidence-based medical research raised regarding medicinal plants and herbs?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** Herb-induced liver injury (HILI) and hepatotoxicity.

**Evidence:** pone.0312962.pdf · page 14

> contemporary evidence-based medical research has raised concerns about potential adverse effects on the liver, such as herb-induced liver injury (HILI) and hepatotoxicity [37, 38].

---
## real-0034 (heldout)

**Question:** Where is Steven A. Carr currently serving as Director of Proteomics?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** Broad Institute of MIT and Harvard

**Evidence:** zjw2214.pdf · page 1

> Steven A. Carr is Director of Proteomics at the Broad Institute of MIT and Harvard (Fig. 1).

---
## real-0024 (heldout)

**Question:** What specific treatment did the kabiraj suggest for the pregnant niece who had developing jaundice after a doctor only advised her to rest?

**Answerable:** True  
**Type:** factual  
**Verified by:** auto  
**Reference:** Drinking three chanted coconuts for three days.

**Evidence:** pone.0312962.pdf · page 9

> So, we sought a second opinion from a kabiraj (traditional healer). He suggested drinking three chanted coconuts for three days.

---
## real-0005 (dev)

**Question:** What methodology is used to aggregate normalized metrics into a single unified score in the conception of NBRS?

**Answerable:** True  
**Type:** method  
**Verified by:** auto  
**Reference:** Arithmetic mean

**Evidence:** Ayush & Aman - BIAS IEEE PAPER.pdf · page 3

> Step 2: Aggregate normalized metrics via arithmetic mean to produce single unified score (Equation 2).

---
## real-0016 (dev)

**Question:** What total daily dose schedule is noted as tolerated for veliparib as a single agent?

**Answerable:** True  
**Type:** numeric  
**Verified by:** auto  
**Reference:** 800 mg

**Evidence:** esmoopen-2020-000871.pdf · page 7

> While veliparib is tolerated at 400 mg two times per day (total daily dose of 800 mg) on a continuous dosing schedule as a single agent and shows activity in breast cancer gene (BRCA)-­ mutant patients at this dose,27–29 the clinical trials that we evaluated that combined veliparib with cytotoxic agents (8788, 9026, E2511 and S1513) used veliparib at a dose per unit time reduced by 75% to more than 90% compared with its single-­agent dose per unit time.

---
## real-0025 (dev)

**Question:** According to the study's demographic findings, what percentages of older adults (50+ years), rural residents, and individuals with no or primary education were more likely to go for traditional treatments?

**Answerable:** True  
**Type:** numeric  
**Verified by:** auto  
**Reference:** 71% for older adults (50+ years), 68% for rural residents, and 72% for individuals with no or primary education.

**Evidence:** pone.0312962.pdf · page 14

> Older adults (71% for 50+ years), rural residents (68%), and indi- viduals with no or primary education (72%) were more likely to go for traditional treatments.

---
## real-0026 (dev)

**Question:** What percentage of urban people with access to modern healthcare incorporated traditional practices according to the study?

**Answerable:** True  
**Type:** numeric  
**Verified by:** auto  
**Reference:** 57% of 200 urban people.

**Evidence:** pone.0312962.pdf · page 14

> While our study found that rural residents (68% of 200 rural people) were more likely to use tradi- tional methods, a considerable percentage (57% of 200) of urban people with access to modern healthcare also incorporated these practices.

---
## real-0013 (dev)

**Question:** How many trials out of the 43 evaluating experimental agents without documented single-agent activity were considered positive based on their protocol-defined criteria?

**Answerable:** True  
**Type:** numeric  
**Verified by:** auto  
**Reference:** 5

**Evidence:** esmoopen-2020-000871.pdf · page 6

> Only 5 of 43 (11.6%) trials evalu- ating experimental agents without documented single-­ agent activity were considered positive based on their protocol-­defined criteria for success.

---
## real-0014 (dev)

**Question:** What hazard ratio for progression-free survival was reported for study S1406 when evaluating the addition of vemurafenib to irinotecan and cetuximab?

**Answerable:** True  
**Type:** numeric  
**Verified by:** auto  
**Reference:** 0.042

**Evidence:** esmoopen-2020-000871.pdf · page 6

> The study was convincingly positive, with a HR for PFS of 0.042 (p<0.001).

---
## real-0019 (heldout)

**Question:** What was the precise median patient age recorded across all clinical trial participants evaluated in the CTEP database review?

**Answerable:** False  
**Type:** numeric  
**Verified by:** auto  
**Reference:** (none)

**Evidence:** none (generated as unanswerable)

---
## real-0003 (heldout)

**Question:** What percentage reduction in temporal bias consistency was achieved when Thambi et al. extended fairness constraints to video generation?

**Answerable:** True  
**Type:** numeric  
**Verified by:** auto  
**Reference:** 17-23%

**Evidence:** Ayush & Aman - BIAS IEEE PAPER.pdf · page 9

> Thambi et al. [48] extended this to video generation through temporal fairness constraints, achieving 17-23% reduction in temporal bias consistency while maintaining output quality.

---
## real-0015 (heldout)

**Question:** According to Table 4, what was the proportion of positive trials for the active single-agent activity category?

**Answerable:** True  
**Type:** numeric  
**Verified by:** auto  
**Reference:** 0.43

**Evidence:** esmoopen-2020-000871.pdf · page 6

> Active 4 3 0.43 (0.10 to 0.82) –

---
## real-0022 (heldout)

**Question:** What specific odds ratio is associated with a lack of information about conventional treatments for jaundice as a pull factor for traditional medicine?

**Answerable:** True  
**Type:** numeric  
**Verified by:** auto  
**Reference:** The odds ratio is 13.82 with a 95% confidence interval of 4.62 to 41.33.

**Evidence:** pone.0312962.pdf · page 2

> pull factors were accessibility of TM (OR: 11.18, 95% CI: 4.03–31.00), perceived effective- ness of TM (OR: 3.45, 95% CI: 1.05–11.37), personal testimonials (OR: 7.55, 95% CI: 2.75– 20.69), lower costs of TM (OR: 10.48, 95% CI: 4.30–25.54) and lack of information about conventional treatments for jaundice (OR: 13.82, 95% CI: 4.62–41.33).

---
